These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 18588853

  • 1. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis.
    Hikami K, Ehara Y, Hasegawa M, Fujimoto M, Matsushita M, Oka T, Takehara K, Sato S, Tokunaga K, Tsuchiya N.
    Biochem Biophys Res Commun; 2008 Aug 29; 373(3):403-7. PubMed ID: 18588853
    [Abstract] [Full Text] [Related]

  • 2. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V, Manetti M, Pacini A, Tolusso B, Fatini C, Toscano A, Cipriani P, Guiducci S, Bazzichi L, Codullo V, Ruocco L, Dell'orso L, Carubbi F, Marrelli A, Abbate R, Bombardieri S, Ferraccioli G, Montecucco C, Valentini G, Matucci-Cerinic M, Ibba-Manneschi L, Giacomelli R.
    Ann Rheum Dis; 2009 Apr 29; 68(4):584-90. PubMed ID: 18445624
    [Abstract] [Full Text] [Related]

  • 3. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I, Kawaguchi Y, Kawasaki A, Hasegawa M, Ohashi J, Hikami K, Kawamoto M, Fujimoto M, Takehara K, Sato S, Hara M, Tsuchiya N.
    Arthritis Rheum; 2009 Jun 29; 60(6):1845-50. PubMed ID: 19479858
    [Abstract] [Full Text] [Related]

  • 4. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
    Beretta L, Cappiello F, Moore JH, Barili M, Greene CS, Scorza R.
    Arthritis Rheum; 2008 Jul 15; 59(7):974-83. PubMed ID: 18576303
    [Abstract] [Full Text] [Related]

  • 5. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L, Cappiello F, Barili M, Scorza R.
    Tissue Antigens; 2007 Apr 15; 69(4):305-12. PubMed ID: 17389013
    [Abstract] [Full Text] [Related]

  • 6. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
    Otieno FG, Lopez AM, Jimenez SA, Gentiletti J, Artlett CM.
    Tissue Antigens; 2007 Jun 15; 69(6):583-91. PubMed ID: 17498268
    [Abstract] [Full Text] [Related]

  • 7. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
    Mattuzzi S, Barbi S, Carletto A, Ravagnani V, Moore PS, Bambara LM, Scarpa A.
    J Rheumatol; 2007 May 15; 34(5):997-1004. PubMed ID: 17444587
    [Abstract] [Full Text] [Related]

  • 8. Association of the FAM167A-BLK region with systemic sclerosis.
    Ito I, Kawaguchi Y, Kawasaki A, Hasegawa M, Ohashi J, Kawamoto M, Fujimoto M, Takehara K, Sato S, Hara M, Tsuchiya N.
    Arthritis Rheum; 2010 Mar 15; 62(3):890-5. PubMed ID: 20131239
    [Abstract] [Full Text] [Related]

  • 9. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
    Rueda B, Broen J, Torres O, Simeon C, Ortego-Centeno N, Schrijvenaars MM, Vonk MC, Fonollosa V, van den Hoogen FH, Coenen MJ, Sanchez-Román J, Aguirre-Zamorano MA, García-Portales R, Pros A, Camps MT, Gonzalez-Gay MA, Martin J, Radstake TR.
    Ann Rheum Dis; 2009 Feb 15; 68(2):253-6. PubMed ID: 18713787
    [Abstract] [Full Text] [Related]

  • 10. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N, Kuroki K, Fujimoto M, Murakami Y, Tedder TF, Tokunaga K, Takehara K, Sato S.
    Arthritis Rheum; 2004 Dec 15; 50(12):4002-7. PubMed ID: 15593213
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.
    Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R.
    Rheumatology (Oxford); 2003 Nov 15; 42(11):1295-8. PubMed ID: 12867583
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology.
    Beretta L, Bertolotti F, Cappiello F, Barili M, Masciocchi M, Toussoun K, Caronni M, Scorza R.
    Hum Immunol; 2007 Jul 15; 68(7):603-9. PubMed ID: 17584583
    [Abstract] [Full Text] [Related]

  • 13. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA.
    Arthritis Rheum; 2007 Aug 15; 56(8):2740-6. PubMed ID: 17665460
    [Abstract] [Full Text] [Related]

  • 14. Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.
    Yoo KH, Kim SK, Chung JH, Chang SG.
    J Korean Med Sci; 2011 May 15; 26(5):659-64. PubMed ID: 21532858
    [Abstract] [Full Text] [Related]

  • 15. TCRBV20S1 and TCRBV3S1 gene segment polymorphisms in systemic sclerosis.
    Bredemeier M, Chies JA, Wieck A, Capobianco KG, Pitrez EH, Rohde LE, Pinotti AF, Brenol JC, Xavier RM.
    J Rheumatol; 2008 Jun 15; 35(6):1058-63. PubMed ID: 18412309
    [Abstract] [Full Text] [Related]

  • 16. Increased serum soluble CD40 levels in patients with systemic sclerosis.
    Komura K, Fujimoto M, Matsushita T, Yanaba K, Kodera M, Kawasuji A, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2007 Feb 15; 34(2):353-8. PubMed ID: 17295440
    [Abstract] [Full Text] [Related]

  • 17. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E, Granel B, Sibilia J, Tiev K, Mouthon L, Cracowski JL, Carpentier PH, Amoura Z, Fajardy I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore Y.
    Arthritis Rheum; 2009 Aug 15; 60(8):2472-9. PubMed ID: 19644887
    [Abstract] [Full Text] [Related]

  • 18. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K, Fujimoto M, Hasegawa M, Ogawa F, Hara T, Muroi E, Takehara K, Sato S.
    J Rheumatol; 2008 Jan 15; 35(1):120-5. PubMed ID: 18085738
    [Abstract] [Full Text] [Related]

  • 19. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).
    Alizadeh BZ, Broen J, Rueda B, Hesselstrand R, Wuttge D, Simeon C, Ortego-Centeno N, Gonzalez-Gay MA, Pros A, Herrick A, Worthington J, Denton C, Fonseca C, Riemekasten G, Vonk MC, van den Hoogen F, Guiducci S, Matucci-Cerinic M, Scorza R, Beretta L, Airó P, Coenen M, Martin J, Koeleman BP, Radstake TR, EUSTAR.
    J Rheumatol; 2010 Aug 01; 37(8):1673-9. PubMed ID: 20551103
    [Abstract] [Full Text] [Related]

  • 20. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    Carulli MT, Handler C, Coghlan JG, Black CM, Denton CP.
    Ann Rheum Dis; 2008 Jan 01; 67(1):105-9. PubMed ID: 17604287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.